5 good reasons for the FDA to give full approval to COVID-19 vaccines: Analysis

The FDA's full approval of Pfizer's coronavirus vaccine, expected as early as this coming week, could make a marked difference in improving health care and saving lives.

The Biden administration announced on Wednesday that it will roll out COVID-19 booster shots for many Americans starting in mid-September. But there's another date that many are anticipating. As early as this coming week, the U.S. Food and Drug Administration is expected to give full approval to Pfizer-BioNTech's coronavirus vaccine -- the first COVID-19 vaccine expected to receive that endorsement. The FDA's approval might seem like a minor technical move to some. But full approval of all three COVID-19 vaccines is an important step that can make a difference in reducing COVID-19 infection and mortality rates, improving health care delivery and saving lives. Here's why: